Latka logo
Bioinformatix logo

Bioinformatix

Boston, Massachusetts, United States

2021 Revenue

$112.6K

Team

3

Founded

2015

Bioinformatix Revenue (2021)

Bioinformatix generated $112.6K in revenue in 2021.

Developer of a cloud based platform designed to operationalize medication intelligence. The company's Rx&You platform utilises artificial intelligence to remotely monitors patient medication behaviour in real-time across their whole regimen, and intervenes when appropriate to help solve medication non-adherence, and pharmacovigilance, and coordinates care, enabling healthcare providers to solve polypharmacy.

Last updated

Bioinformatix Revenue

In 2021, Bioinformatix's revenue reached $112.6K.

Bioinformatix Revenue GrowthReported revenue / ARR over time$0$25K$50K$75K$100K$125K2015201620172018201920202021$0$112.6KSource: GetLatka.com
YearMilestoneSource
2021Bioinformatix Hit $112.6k revenue in April 2021Not recorded
2015Launched with $0 revenue

Founder / CEO

We don't have Bioinformatix's Founder / CEO on record yet.

Bioinformatix Employees & Team Size

Bioinformatix employs approximately 3 people as of 2026.

Bioinformatix Team GrowthReported headcount over time01223420152016201720182019202020210033Source: GetLatka.com
YearMilestoneSource
2021Reached 3 employees (April 2021)Not recorded

Frequently Asked Questions about Bioinformatix

Is Bioinformatix still operating?

No. Bioinformatix has shut down.

What is Bioinformatix's revenue?

As of 2021, Bioinformatix generated $112.6K in revenue.

When was Bioinformatix founded?

Bioinformatix was founded in 2015.

How many employees does Bioinformatix have?

As of 2021, Bioinformatix had 3 employees.

Where is Bioinformatix headquartered?

Bioinformatix is headquartered in Boston, Massachusetts, United States.

Compare Bioinformatix to the industry

Bioinformatix operates across multiple industries. Browse revenue, funding, and growth data for Bioinformatix in each sector below.

Data and Sources

All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.

Claim this profile